Christopher W West - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|September 12, 2018

Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosisImadul Islam, Shendong Yuan, Christopher W West, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channelsKen McCormack, Sonia Santos, Mark L Chapman, et al.

Journal of Medicinal Chemistry|July 7, 2017

Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Bioorganic & Medicinal Chemistry Letters|September 12, 2018

Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosisImadul Islam, Shendong Yuan, Christopher W West, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 3, 2013

Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channelsKen McCormack, Sonia Santos, Mark L Chapman, et al.

Journal of Medicinal Chemistry|July 7, 2017

Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.

Pageof 3